2013 Program

Tuesday, October 15, 2013
8:00-4:30 Informatics for Nanomanufacturing
Workshop Agenda

Workshop Chairs:
Mark Tuominen, Director, National Nanomanufacturing Network
Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network

Wednesday, October 16, 2013
7:45 Registration Opens
Continental Breakfast served in the Showcase/Poster Session Area
8:30-9:00 Opening Remarks
Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network
Vincent Caprio, Executive Director, NanoBusiness Commercialization Association
9:00-9:30 Keynote: Dr. Rutledge Ellis-Behnke, Ph.D., Research Affiliate, Brain & Cognitive Sciences, MIT/Prof, University of Heidelberg/Director, Nanomedicine Translational Think Tank
9:30-10:00 Keynote: Dr. Anita Goel, MD, Ph.D., Chairman & CEO, Nanobiosym
10:00-10:30 Keynote: HzO Case Study of Growth Jim Phillips, Chairman/CEO, NanoMech Inc.
10:30-11:30 How Can Nanotech Companies Build Long-Term Patent Portfolios That Will Protect Investors & Cover Future Product Designs?

The Supreme Court has been subjecting US patents to heightened scrutiny in cases like Myriad, where it struck down a claim covering a “product of nature.” Another round of legislative changes to US patent law has further complicated patent planning for companies. Against a backdrop of heightened judicial scrutiny and changing laws, nanotech companies need to build long-term patent portfolios that protect investors, yet are flexible enough to protect future product designs or even completely different application areas than those envisioned by company founders. The long product development cycles for nanotech make it especially hard to build a patent portfolio that will satisfy these objectives. Panelists will provide insights into how nano innovators can meet these challenges and profit from opportunities created by the changing US patent environment. Among other topics, panelists will discuss:

  • What are the current trends in nanotech patenting at the US Patent Office?
  • What kinds of patents can safely withstand Supreme Court scrutiny today?
  • What opportunities have been created for avoiding competitor patents under the new laws and court decisions?
  • How can a patent portfolio cover future changes to product designs and new application areas?

Moderator: Steve Maebius, Partner, Foley & Lardner LLP
Speakers: Andrew Baluch, Special Counsel, Foley & Lardner LLP
Hans Sauer, Ph.D., JD, Associate General Counsel for Intellectual Property, BIO
Jerry Lorengo, Director of Technology Center 1600, USPTO

11:30-12:30 State of the Union - Nanotechnology Environmental Health Safety (EHS) 2014

Lynn L. Bergeson, Managing Director, Bergeson & Campbell, P.C.

12:30-1:15 Lunch
1:15-2:00 Keynote Panel: NNI - 10 Year Retrospective/Look Forward

Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network
Vincent Caprio, Executive Director, NanoBusiness Commercialization Association

Nanomanufacturing Nanomedicine/Research Centers - The Role of Innovation
2:00-2:30 Paul S. Clayson, President & CEO, HzO, Inc. 2:00-3:00 The Multistage Nanovector Delivery System: From Bench to...almost Clinic
Jason H. Sakamoto, Ph.D., Co-Chair, Assistant Member, Department of Nanomedicine, Houston Methodist Research Institute

A Revolution in the Treatment of Metastatic Cancer
Steve Klemm, Chief Scientific Officer, Leonardo Biosystems Inc.

2:30-3:00 Carbon Nanotubes Manufacturing & Applications
David J. Arthur, CEO, SouthWest NanoTechnologies Inc.
3:00-3:30 Joe Piché, CEO, Eikos 3:00-4:00 From Technology Push to Market Pull: The Role of Research Centers in the Nanotechnology Innovation Ecosystem

Cluster university R&D investments into a research center around a specific science or engineering opportunity and a vibrant innovation economy will result, right? Not likely. Most NSF, NIH or even state-funded university research centers do not maximize their regional economic outcome potential. Well-designed research centers, though, can help bring an innovation ecosystem together through increased attracted R&D funding, the spillover effects of knowledge dissemination, student learning experiences, local early access to new technologies, and, yes, even more successful companies and local job creation. In this practitioner-focused session, we’ll examine innovative research centers taking more holistic approaches to help bring innovation ecosystems together – and the lessons they’ve learned on what works and what doesn’t.

The Role of Research Centers in the Nanotechnology Innovation Ecosystem
Anthony P. Green, Vice President, Technology Commercialization Group - Life Sciences and Ben Franklin Director, The Nanotechnology Institute & Energy Commercialization Institute

From (nano)Technology Push to Market Pull: the ONAMI Model
Robert. D. "Skip" Rung, President and Executive Director, Oregon Nanoscience and Microtechnologies Institute

Utilizing the Oregon Startup Ecosystem
Dr. Wei Wang, Research Scientist, Amorphyx, Inc.
Dr. Sean Muir, Senior Research Scientist, Amorphyx, Inc.

3:30-4:00 pixelligent - The Clear Solution
Dan Russell, Senior Vice President, Manufacturing & Operations, Pixelligent Technologies, LLC
4:00-4:30 Scott Jacobs, Vice President Product Development, Treasurer & Director, Quantum Confined 4:00-4:30 Nano Patents for Cash Flow and Stock Price, and Financing for Nano Patent Monetization and Enforcement
Stephen C. Glazier, Partner, K&L Gates LLP
4:30-5:00 Keynote: Ram Trichur, Carbon Electronics Business Development Manager, Brewer Science
5:00-5:30 Keynote: Scott Livingston, Chairman & CEO, Livingston Securities
Sponsored by
Solvay Woodcock Washburn

Located at the Singh Nanotechnology Center

Greeting: Mark G. Allen, Ph.D., Scientific Director, Krishna Singh Center for Nanotechnology, Professor, Department of Electrical & Systems Engineering, School of Engineering & Applied Sciences, University of Pennsylvania

Thursday, October 17, 2013
7:45 Registration Opens
Continental Breakfast served in the Showcase/Poster Session Area
8:25 Opening Remarks
Vincent Caprio, Executive Director, NanoBusiness Commercialization Association
Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network
8:30-9:00 Keynote: Dr. Larry Hough, Lab Manager: Complex Assemblies of Soft Matter Laboratory (COMPASS UMI 3254), Corporate Research & Innovation, Solvay
9:00-9:30 Keynote: Inframat Corporation

David E. Reisner, Ph.D., Founder, Director, International Sales Leader, The Nano Group, Inc.

9:30-10:00 Keynote: An Overview of Some of the More Interesting Nanotechnology Inventions – One Patent Attorney’s Perspective

Jeffrey H. Rosedale, Partner, Woodcock Washburn LLP

Graphene Development & Commercialization Nanotechnology and the Law
Sponsored by
Graphene Stakeholder's Association
Graphene: The Next Wonder Material?
10:00-11:00 Product Stewardship for Nanotechnology Products: Current Regulations and Risk Management
Proactive approaches to product stewardship help successfully place products of nanotechnology into commercial markets. Understanding the regulatory frameworks that govern the end use of the product(s) is critical to successful commercialization. We review recent and emerging regulations in the US and Europe that govern the use of nanotechnology products. Even in the absence of existing regulations, a proactive approach requires a science-based evaluation of whether existing risk management is adequate or requires additional measures to address uncertainties from data or knowledge gaps.

Risk Management and Minimizing Legal Exposure
Michael J. Sullivan, Partner, Womble, Carlyle, Sandridge and Rice

Product Stewardship for Nanotechnology Products: Current Regulations and Risk Management
Linda D. Dell, MS, Senior Science Manager; Environ Corp.

10:00-11:00 Session 1: Developing Graphene: Standards, Tools, Nomenclature

Moderator: Dr Alan Rae, Co-founder, Graphene Stakeholders Association

Graphene Measurement and Standards
Dr. Andrew Pollard, Research Scientist, National Physical Laboratory

Metrology Solutions for 2-D Nanomaterials
Dr. Toby Sainsbury, Research Scientist, National Physical Laboratory

Dr. Angela Hight Walker, Senior Scientist, NIST

11:00-12:00 Session 2: Graphene Production: Recipes for Success

Moderator: Keith Blakely, Co-founder, Graphene Stakeholders Association

Graphene and Beyond: Recent Progress in the Production of 2D Materials
Dr. Elena Polyakova, Founder and CEO, Graphene Labs

Commercialisation of Graphenes
Ray Gibbs, Commercial Director, Haydale

John Biondi, CEO, Xolve Inc.

11:00-12:00 Nanotechnology and OEHS Harmonization; A Global Approach

Materials Science has been integral to the advancement of mankind since time immemorial. Because of the many advances these technologies have introduced, we’re generally accustomed to an ever-increasing continuum of change while also accepting the inherent risks that occur. With nanotechnology, however, society has taken a somewhat tempered approach to this progress and balanced benefit against a notably more cautious approach. This is evidenced by the National Nanotechnology Initiative which mandates that Occupational, Environmental, Health and Safety (OEHS) be as critical a component to the science of nanotechnology as the materials sciences in which it exists. The presentation offered here will provide participants with a global overview of current good practices associated with Nanotechnology OEHS and detail those programs under development to minimize and control these unique risks.

Donald Ewert, IH, VP-Field Services, nanoTox, Inc.
Moderator: Vincent Caprio, Executive Director, NanoBusiness Commercialization Association

12:00-1:00 Session 3: Graphene Roadmap - Innovation and Commercialization Prospects

Moderator: Stephen Waite, Co-founder, Graphene Stakeholders Association

Graphene Frontiers
Mike Patterson, CEO, Graphene Frontiers

High Performance Products Powered by Graphene
Jon Myers, CEO, Graphene Technologies

1:00-1:45 Lunch
1:45-2:00 The NCMS-NSF Survey of Nanotechnology in US Manufacturing Industry
Manish Mehta, Ph.D., Director, Principal Investigator - 2013 NCMS-NSF Nanotechnology Commercialization Readiness Study, National Center for Manufacturing Sciences (NCMS)
Nanobiotechnology Commercialization
Nanobiotechnology Commercialization
Moderator: Anthony P. Green, Vice President, Technology Commercialization Group - Life Sciences and Ben Franklin Director, The Nanotechnology Institute & Energy Commercialization Institute
2:00-2:30 Nanobiotechnology for Tissue Engineering and Regenerative Medicine
Peter I. Lelkes, Temple University & Eqalix LLC
2:30-3:00 Acoustic tweezers: manipulating particles, cells, and organisms using standing surface acoustic waves (SSAW)

The ability to manipulate cells and microparticles in a biocompatible and dexterous manner is critical for numerous biological studies and applications such as cell-cell communication, biosensing, tissue engineering, and regenerative medicine. Here we summarize our recent progress on an “acoustic tweezers” technique that utilizes standing surface acoustic wave (SSAW) to manipulate particles, cells, and organisms. This technique is capable of manipulating cells and microparticles regardless of shape, size, charge or polarity. Its power intensity, approximately 107 times lower than that of optical tweezers, compares favorably with those of other active patterning methods. Cell viability, proliferation, and apoptosis studies have revealed the technique to be biocompatible. The aforementioned advantages, along with this technique’s simple design and ability to be miniaturized, render the “acoustic tweezers” technique a promising tool for various applications in biology, chemistry, engineering, and materials science.

Prof. Tony Jun Huang, CTO, Ascent Bio-Nanotechnologies, Inc.

3:00-3:30 Bernardo Cordovez, President, Optofluidics, Inc.
3:30-4:15 FBI Counterintelligence Strategic Partnership
4:15-5:00 Overview
Griffith A. Kundahl, Vice President, Business Development & Government Relations, Nano Risk Assessment, Inc.
Vincent Caprio, Executive Director, NanoBCA